The English national screening programme for sight-threatening diabetic retinopathy
- PMID: 18416946
- DOI: 10.1258/jms.2008.008015
The English national screening programme for sight-threatening diabetic retinopathy
Abstract
Objectives: The main objective of the national screening programme is to reduce the risk of sight loss among people with diabetes due to diabetic retinopathy (DR).
Methods: Offering two-field mydriatic digital photographic screening to all people with diabetes in England over the age of 12 years.
Stage of development: The programme is in its infancy, receiving the first year's annual reports from approximately 96 screening programmes, each of which have developed to offer screening to a minimum number of 12,000 people with diabetes, which would cover a population of 350,000 people with 3.4% diabetes prevalence. The national programme has commenced the External quality assurance (QA) programme in order to achieve and sustain the highest possible standards.
Potential benefits: England has a population of two million people with diabetes over the age of 12 and it is believed that there is a prevalence of blindness of 4200 and an annual incidence of blindness of 1280 people with diabetes. This programme has the potential to reduce the prevalence of blindness in England from 4200 people to 1000 people and a conservative estimate of reducing the annual incidence of DR blindness by one-third would save 427 people per annum from blindness. These figures are based on the UK certification of blindness but if World Health Organization (WHO) definitions are used the prevalence, incidence and potential reductions in blindness are much greater.
Similar articles
-
The English National Screening Programme for diabetic retinopathy 2003-2016.Acta Diabetol. 2017 Jun;54(6):515-525. doi: 10.1007/s00592-017-0974-1. Epub 2017 Feb 22. Acta Diabetol. 2017. PMID: 28224275 Free PMC article. Review.
-
Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.Acta Ophthalmol Scand Suppl. 1997;(223):1-76. Acta Ophthalmol Scand Suppl. 1997. PMID: 9559048
-
The incidence of visual impairment due to diabetic retinopathy in Leeds.Eye (Lond). 2006 Apr;20(4):455-9. doi: 10.1038/sj.eye.6701908. Eye (Lond). 2006. PMID: 15905872
-
The contribution of the English NHS Diabetic Eye Screening Programme to reductions in diabetes-related blindness, comparisons within Europe, and future challenges.Acta Diabetol. 2021 Apr;58(4):521-530. doi: 10.1007/s00592-021-01687-w. Epub 2021 Apr 8. Acta Diabetol. 2021. PMID: 33830332 Free PMC article.
-
The English national risk-reduction programme for preservation of sight in diabetes.Mol Cell Biochem. 2004 Jun;261(1-2):183-5. doi: 10.1023/b:mcbi.0000028754.70862.13. Mol Cell Biochem. 2004. PMID: 15362502 Review.
Cited by
-
Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment.Exp Ther Med. 2013 May;5(5):1393-1396. doi: 10.3892/etm.2013.1021. Epub 2013 Mar 20. Exp Ther Med. 2013. PMID: 23737887 Free PMC article.
-
The Discovery of MK-4256, a Potent SSTR3 Antagonist as a Potential Treatment of Type 2 Diabetes.ACS Med Chem Lett. 2012 May 7;3(6):484-9. doi: 10.1021/ml300063m. eCollection 2012 Jun 14. ACS Med Chem Lett. 2012. PMID: 24900499 Free PMC article.
-
Clinical Components of Telemedicine Programs for Diabetic Retinopathy.Curr Diab Rep. 2016 Dec;16(12):129. doi: 10.1007/s11892-016-0813-8. Curr Diab Rep. 2016. PMID: 27796779 Review.
-
The changing role of the endocrinologist in the care of patients with diabetic retinopathy.Endocrine. 2014 Jun;46(2):199-208. doi: 10.1007/s12020-013-0119-4. Epub 2014 Jan 3. Endocrine. 2014. PMID: 24385265 Review.
-
A simple risk stratification for time to development of sight-threatening diabetic retinopathy.Diabetes Care. 2013 Mar;36(3):580-5. doi: 10.2337/dc12-0625. Epub 2012 Nov 12. Diabetes Care. 2013. PMID: 23150285 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
